Cartalax

Origin of the bioregulator family

The peptide bioregulator programme began with peptide fractions extracted from animal organs — thymus, pineal, cartilage, vessel wall — which were later analysed to identify the short sequences thought to carry the activity. Cartalax belongs to the second, fully synthetic generation of that work: defined tripeptides made by solid-phase synthesis rather than tissue extracts of uncertain composition. Its relationship to Sigumir is exactly that of a synthetic single sequence to a natural mixture.

The proposed mechanism

• Chondrocyte culture models, with reported effects on expression of cartilage matrix components including collagen type II and aggrecan
• Cellular senescence markers in serially passaged connective-tissue cell lines
• Comparative studies across the tripeptide family, testing whether single residue substitutions redirect apparent tissue specificity
• DNA-binding and molecular-docking studies examining sequence preference of short acidic peptides
• Aged-animal models reporting changes in connective-tissue histology

Reading the evidence critically

Let the sealed vial reach room temperature before opening so moisture does not condense onto the lyophilized cake. AED is a small, strongly acidic peptide that dissolves quickly — add bacteriostatic or sterile water slowly down the inner wall and swirl gently until clear rather than shaking. Note that the resulting solution is acidic; for cell-culture work the stock is normally buffered or diluted into medium and the final pH checked, since unbuffered addition can shift the culture pH measurably. Store the sealed powder at −20 °C protected from light and moisture, keep reconstituted solution at 2–8 °C, and record lot number, diluent, volume and reconstitution date for each vial.